Clinical Trial Update: Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease [Phase 3]

View source ↗

Summary

Phase 3 trial assessing edoxaban to prevent thrombotic events in children at risk due to cardiac disease; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Disease

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Cardiac Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-07-26